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Abstract
Most commercially available therapeutic honey is derived from flowering Leptospermum
scoparium (manuka) plants from New Zealand. Australia has more than 80 Leptospermum
species, and limited research to date has found at least some produce honey with high non-
peroxide antibacterial activity (NPA) similar to New Zealand manuka, suggesting Australia
may have a ready supply of medical-grade honey. The activity of manuka honey is largely
due to the presence of methylglyoxal (MGO), which is produced non-enzymatically from
dihydroxyacetone (DHA) present in manuka nectar. The aims of the current study were to
chemically quantify the compounds contributing to antibacterial activity in a collection of
Australian Leptospermum honeys, to assess the relationship between MGO and NPA in
these samples, and to determine whether NPA changes during honey storage. Eighty differ-
ent Leptospermum honey samples were analysed, and therapeutically useful NPA was
seen in samples derived from species including L. liversidgei and L. polygalifolium. Excep-
tionally high levels of up to 1100 mg/kg MGO were present in L. polygalifolium honey sam-
ples sourced from the Northern Rivers region in NSW and Byfield, QLD, with considerable
diversity among samples. There was a strong positive relationship between NPA and MGO
concentration, and DHA was present in all of the active honey samples, indicating a potential
for ongoing conversion to MGO. NPA was stable, with most samples showing little change
following seven years of storage in the dark at 4˚C. This study demonstrates the potential
for Australian Leptospermum honey as a wound care product, and argues for an extension
of this analysis to other Leptospermum species.
Introduction
Honey has been used therapeutically by many cultures for millennia and has re-emerged as a
topical treatment for wound and skin infections, mainly due to its antimicrobial activity [1]. In
particular, honey produced from the Leptospermum scoparium (manuka) plant from New Zea-
land exhibits broad-spectrum antimicrobial activity against a diverse range of bacterial and
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yeast pathogens, and is equally effective against multi-drug resistant bacteria [2–6]. Resistance
to the antimicrobial effects of manuka honey on growing bacterial cells has not been reported
nor has it been induced under laboratory conditions [2, 3]. There are a number of medicinal
honey products on the market that use manuka honey from New Zealand, or the Australian
equivalent produced from other Leptospermum species. However, despite being registered
with medical regulatory authorities as wound care agents in Australia, Canada, the European
Union, Hong Kong, New Zealand and the USA, their use in mainstream medicine remains
limited [7], largely due to a lack of understanding of all of the mechanisms by which Leptosper-
mum honey kills pathogens. The growing crisis of antibiotic resistance [8] has revived interest
in the clinical use of honey, particularly in wound care and its efficacy against drug-resistant
pathogens.
Several properties of honey contribute to its antimicrobial activity. In most honeys, it is the
high osmolarity, low pH, and, most predominantly, the enzymatic production of hydrogen
peroxide that exerts an antimicrobial effect [9]. The level of antimicrobial activity is highly var-
iable and depends on the floral source, processing and storage conditions of the honey, prevail-
ing environmental conditions that affect the physiology of the floral species, and bee-related
factors such as age or colony health [10–16].
Antibacterial activity that remains in honey following neutralisation of hydrogen peroxide
is commonly referred to as “non-peroxide activity” (NPA). NPA is equivalent to the “Unique
Manuka Factor” (UMF1), a trademark registered by the UMF Honey Association and avail-
able for use under licence by producers of manuka honey from New Zealand. NPA was first
identified in manuka honey from New Zealand and is closely associated with the floral source
as it is generally derived from phytochemical components produced by manuka and related
Leptospermum species [10, 17], although a small number of non-Leptospermum honeys have
also shown this type of activity [10, 18–21]. Honey with high NPA is highly sought after for
use in medical-grade honey products as it is not destroyed by the catalase present in body flu-
ids, and can withstand gamma irradiation [22], which is used for sterilisation. The compound
primarily responsible for the NPA of manuka honey has been identified as methylglyoxal
(MGO), which forms from the nectar-derived compound, dihydroxyacetone (DHA), during
the ripening of honey [23–25]. Consequently, the level of MGO in honey is dictated by factors
including the DHA content of the nectar, the extent of Leptospermum bloom and the foraging
behaviour of honey bees [25, 26].
There are a number of microbiological and chemical tests that are used in the honey indus-
try to determine the suitability of honey as an antibacterial product. Antibacterial activity is
generally determined by an agar well diffusion method, which measures the extent to which
Staphylococcus aureus is inhibited with reference to a phenol standard [10]. NPA is often mar-
keted in New Zealand honey as the UMF, with a rating>10+ considered therapeutically active.
DHA, which converts to MGO during storage, is an indicator of the potential for honey to
increase in activity. DHA and MGO levels in honey can be directly assessed by high-perfor-
mance liquid chromatography (HPLC) [26, 27]. MGO levels can then be used to estimate the
NPA, where a honey with MGO >260 mg/kg is predicted to have>10+ activity based on the
relationship between MGO and NPA identified previously [23]. Finally, hydroxymethylfur-
fural (HMF), which occurs spontaneously in all honey types, is often quantified by HPLC as a
measure of honey freshness (and as a measure of spoilage) as it increases in concentration with
storage length and temperature. Levels of HMF in honey above 40mg/kg are undesirable as
they can mean honey producers will not be able to sell or export the honey.
The wealth of evidence that supports New Zealand manuka honey as a modern healthcare
option has translated to commercial success for the industry. However, New Zealand will not
be able to support the likely growing demand for medical-grade honey [28]. Furthermore,
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New Zealand honey supply is at risk due to infection of their honey bee (Apis mellifera) popu-
lations by the parasitic varroa mite [29], which is associated with colony collapse disorder, an
alarming phenomenon that significantly threatens global honey production [30]. Australia is
home to 83 of the 87 known Leptospermum species [31, 32] (including L. scoparium [25]) and
is still free of the varroa mite, however very few studies have investigated the properties of
honey derived from Australian Leptospermum honey [2, 12, 27, 33]. In a comprehensive survey
of Australian honey for antibacterial activity, Irish et al. reported high levels of NPA in some
Australian Leptospermum honeys [12], however this work pre-dated the discovery of MGO as
the major antibacterial component of Leptospermum honey, and DHA, MGO and HMF levels
in these honey samples were not ascertained at the time.
The aim of the current study was to revisit the 80 Australian Leptospermum honeys col-
lected by Irish et al. [4] and to determine their levels of DHA, MGO and HMF as well as their
current antibacterial activity (NPA). This study is the first to investigate the relationship
between the NPA of Australian Leptospermum honey and its phytochemical constituents, and
the change in this activity over time. We report a strong positive correlation between MGO
content and NPA in these honeys and also demonstrate that the non-peroxide activity is pre-
served for up to seven years after original harvest when honeys are stored in the dark at 4˚C.
Materials and Methods
Honey samples
Eighty honeys derived from Leptospermum species were selected from the 477 Australian
honey samples collected by Irish et al. [12] between March 2005 and June 2007 (S1 Table).
These samples had been catalogued, stored in sterile specimen jars and refrigerated in the dark
at 4˚C at the University of Sydney, Australia, since collection. A database of information per-
taining to these samples was compiled by Irish et al. [12] that included collection date, geo-
graphic region and floral source. Identification of the floral source of the honey was performed
at the time of collection by the apiarists based on the local floral species in bloom prior to
honey harvesting, location of the apiary and organoleptic characteristics of the honey. The
majority (70) of the 80 Australian Leptospermum honey samples were received from the
Northern Rivers region of NSW, with the remaining collected from various regions across the
country (S1 Fig). All honey samples were identified as being from four monofloral sources
(defined as>50% nectar from one floral source [34]) and four multifloral sources. Multifloral
and monofloral L. polygalifolium honeys from Northern Rivers comprised 55% of the samples
in this collection.
A sample of unprocessed manuka honey and two samples of commercially available Medi-
honeyTM, provided by Comvita New Zealand Ltd., were used as positive controls. Tasmanian
clover honey (with no detectable DHA or MGO) was used as a negative control for chemical
analysis, and was supplied by the University of the Sunshine Coast, Australia. The control
honey samples were also stored at 4˚C and in the dark.
Quantitation of phytochemical components in Australian Leptospermum
honey samples
Chemical analyses of honey samples were performed using methods adapted from Windsor
et al. [27, 35]. Briefly, this method involved accurately weighing 0.30–0.40 g of honeys in dupli-
cate into 75 mm test tubes. Hydroxyacetone internal standard (0.250 ml, 0.528 mg/ml) was
weighed into the test tubes and the entire sample dissolved in 1.2 ml of O-(2,3,4,5,6-penta-
fluorobenzyl) hydroxylamine (PFBHA) reagent (0.2 g per 10 ml 0.1 M citrate buffer at pH 4).
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Derivatisation of MGO, DHA and 5-hydroxymethylfurfural (HMF) with PFBHA took 75 min-
utes. The samples were diluted with water and acetonitrile until homogeneous, and quantified
in duplicate by Reverse Phase-High Performance Liquid Chromatography (RP-HPLC; Perkin
ElmerTM Series 200 HPLC and Autosampler, Binary Pump and Flexar1 Photodiode Array
Detector with a ZORBAC Eclipse Plus column (75 mm x 4.6 mm, 3.5 μm) utilising a 75:25
water: acetonitrile to 100% acetonitrile mobile phase program).
MGO, DHA, HMF (Sigma-Aldrich, St Louis, MO, USA) standards were used for six point
calibration, and hydroxyacetone (Sigma-Aldrich) was used as the internal standard for quanti-
tation. All standard solutions were stored at -20˚C. Quantitation standards were prepared by
dissolving known concentrations of the standard solutions in six aliquots of clover honey
(which has no detectable MGO, DHA or HMF unless spiked).
Chemical profile data analysis. Data collection and peak area integration were com-
pleted with Chromera1 Chromatography Data Systems for Liquid Chromatography. The
calibration curves were derived from the quantitation standards by plotting the masses of
MGO, DHA and HMF in each of the spiked clover honey standards against their peak area
ratios relative to the hydroxyacetone internal standard. The concentration of each com-
pound was determined as mg/kg of honey. Descriptive statistical analysis (i.e. means, stan-
dard deviation, range and medians) was conducted using IBM1 SPSS1 Statistics Version
20 (Armonk, NY, USA).
Determining the non-peroxide antibacterial activity of Australian
Leptospermum honey samples
Non-peroxide antibacterial activity (NPA) of honey samples with reference to phenol were
determined using methods reported in Irish et al. [12]. Staphylococcus aureus ATCC 25923
(Oxoid, Hampshire, UK) was used as the test organism for the phenol assays. Honey solutions
were freshly prepared in a 50% weight per volume (w/v) solution in sterile deionised water,
and further diluted to 25% volume per volume (v/v) in a 2 mg/ml catalase solution (3187
units/mg; Sigma-Aldrich) to remove any hydrogen peroxide activity.
MedihoneyTM (Comvita Ltd., New Zealand) with predetermined UMF1 (>15) and clover
honey (with no detectable NPA) were both prepared with catalase as above, and were included
in each assay as a positive and negative control, respectively. Phenol (Sigma-Aldrich) standards
of 2%, 3%, 4%, 5%, 6%, and 7% v/v were prepared daily in sterile deionised water.
Aliquots (100 μl) of each honey sample and phenol solutions were dispensed into the wells
of the assay plates, in duplicate. Quasi-latin squares were used to randomise the sample distri-
bution and plates were incubated at 37˚C for 18–24 h.
The diameter of each zone of inhibition was measured at perpendicular angles using digital
Vernier callipers (accurate to 0.1 mm; Kinechrome Australia Pty Ltd.). The mean diameter of
the zone of inhibition was calculated and squared, and a standard curve was generated using
the phenol standards (concentration of phenol versus mean squared diameter). The NPA of
honey was calculated using the standard curve, multiplied by 4.69 to account for the dilution
and density of honey (based on a mean honey density of 1.35 mg/ml [36]), and expressed as
the equivalent phenol concentration (% v/v, subsequently referred to as %). Each honey sample
was tested in duplicate on three separate occasions.
Antibacterial activity data analysis. All data were analysed qualitatively and statistical
analysis of change in activity over time was performed with Minitab Express (v.1.3.0) statis-
tical software (State College, PA, USA), using the Wilcoxon signed ranks test. The correla-
tion between NPA and MGO was determined using the Spearman’s Rank Correlation test
performed with R (v. 3.3.1) statistical software (Vienna, Austria).
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Results
Quantitation of DHA, MGO and HMF in Australian Leptospermum honey
samples
Monofloral L. polygalifolium honeys sourced from Northern Rivers (n = 29) and Byfield in
QLD (n = 1) exhibited the highest levels of both MGO and DHA in the study as shown in
Table 1 and S1 Table. Most of these samples (n = 21) possessed MGO levels of>500 mg/kg,
and DHA levels of>2000 mg/kg, with marked variation from one sample to another. Six addi-
tional honeys sourced from Northern Rivers had high levels of MGO including a monofloral
L. liversidgei honey (704 mg/kg), a multifloral L. liversidgei honey (418 mg/kg), an L. laeviga-
tum honey (583 mg/kg) and three multifloral L. semibaccatum samples (407–430mg/kg). The
DHA content for these six honeys ranged considerably (79–2541 mg/kg).
There were five honey samples with10mg/kg MGO (Table 1 and S1 Table). Of these, one
was from Murraylands SA (unspecified Leptospermum sp.), three were from Northern Rivers
(multifloral L. liversidgei, L. laevigatum and L. polygalifolium), and one from the Hunter region
in NSW (multifloral L. laevigatum). These samples also showed minimal quantifiable DHA
(<61 mg/kg).
HMF levels were mostly low, with only seven samples above the acceptable level of>40
mg/kg. When ranked according to the year of collection, the highest HMF concentrations
were found in the oldest honey samples (Table 2 and S1 Table) harvested from hives between
1998 and 2002, which was to be expected as HMF increases with age. HMF levels in the honey
samples did not correlate with MGO or DHA concentrations.
Non-peroxide activity (NPA) of Australian Leptospermum honey
samples
The mean NPA of most of the samples (57 of the 80 samples) was above the previously defined
[12] therapeutically beneficial level of>10% (Table 3 and S2 Table). Honey samples with high
Table 1. Methylglyoxal (MGO) and dihydroxyacetone (DHA) levels in Australian Leptospermum honey samples.
Leptospermum species Regiona No. of samples tested MGOb (mg/kg) DHAc (mg/kg)
Range Mean ± SD Range Mean ± SD
L. continentale Central VIC 2 222–262 242 ± 28 775–1092 934 ± 224
L. laevigatum Central VIC 1 NA 14 ± 0 NA 0 ± 0
Northern Rivers NSW 1 NA 583 ± 9 NA 1485 ± 33
Multifloral L. laevigatum Hunter NSW 1 NA 10 ± 5 NA 0 ± 0
Northern Rivers NSW 1 NA 5 ± 1 NA 12 ± 17
L. liversidgei Northern Rivers NSW 5 208–704 361 ± 205 226–882 454 ± 282
Multifloral L. liversidgei Northern Rivers NSW 13 8–362 113 ± 127 61–818 246 ± 231
L. polygalifolium Byfield QLD 1 NA 1100 ± 57 NA 2182 ± 150
Northern Rivers NSW 28 146–1118 628 ± 243 157–3425 2042 ± 971
Multifloral L. polygalifolium Northern Rivers NSW 12 0–526 313 ± 149 0–1262 689 ± 459
L. semibaccatum multifloral Northern Rivers NSW 4 407–430 419 ± 10 427–736 628 ± 138
Unspecified Leptospermum sp. Murraylands SA 1 NA 0 ± 0 NA 0 ± 0
Northern Rivers NSW 6 418–836 519 ± 158 206–1705 1205 ± 556
Stradbroke Island QLD 1 NA 835 ± 36 NA 2343 ± 131
Unknown 3 126–995 560 ± 5 79–501 255 ± 219
aNSW: New South Wales, QLD: Queensland, SA: South Australia, TAS: Tasmania, VIC: Victoria
bMGO: methylglyoxal
cDHA: dihydroxyacetone. NA: not applicable.
doi:10.1371/journal.pone.0167780.t001
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NPA between 15–20% (n = 29) were mostly monofloral L. polygalifolium and also included
two L. liversidgei, one L. laevigatum and one L. semibaccatum sample, all of which were sourced
from Northern Rivers. The 13 honeys with exceptionally high NPA (>20%) consisted mainly
of L. polygalifolium (n = 9) from Northern Rivers (8 samples) and Byfield (one sample). One L.
liversidgei and three Leptospermum sp. honeys also showed NPA >20%, and these were from
Northern Rivers (n = 1), Stradbroke Island QLD (n = 1) and of unknown geographic origin
(n = 2). There were 22 honey samples that were at least as active as the New Zealand manuka
control (NPA 18.6%) (S2 Table).
Honey samples that did not have detectable NPA (n = 20) were derived from a variety of
Leptospermum species and from different regions, including monofloral L. liversidgei, a multi-
floral L. liversidgei sample, and a multifloral L. laevigatum sample from Northern Rivers and
Hunter; monofloral L. continentale (Central VIC); and unspecified Leptospermum sp. from
Murraylands. There were two samples of L. polygalifolium honey, one monofloral and one
multifloral, that did not have detectable NPA and these were from Northern Rivers.
Table 2. Hydroxymethylfurfural (HMF) concentrations in Australian Leptospermum honey collected between 1998 and 2007.
Year of collection No. samples tested HMF* (mg/kg)
Mean ± SD Range
1998 1 143 NA
2002 7 49 ± 26 4–81
2003 3 21 ± 6 16–27
2004 5 18 ± 7 11–29
2005 43 14 ± 8 0–52
2006 18 12 ± 12 12–33




Table 3. Non-peroxide antibacterial activity of Australian Leptospermum honeys.
Leptospermum species Geographic regiona No. of samples Mean NPAb (%) ± SD
L. continentale Central VIC 2 0 ± 0
L. laevigatum Central VIC 1 0 ± 0
Northern Rivers NSW 1 18.5 ± 0.2
L. laevigatum blend Hunter NSW 1 0 ± 0
Northern Rivers NSW 1 0 ± 0
L. liversidgei Northern Rivers NSW 5 12.2 ± 8
L. liversidgei blend Northern Rivers NSW 13 2.8 ± 5.4
L. polygalifolium Byfield QLD 1 22.9 ± 4.4
Northern Rivers NSW 28 18.9 ± 5.4
L. polygalifoliumblend Northern Rivers NSW 12 11.8 ± 6.2
L. semibaccatum blend Northern Rivers NSW 4 14.8 ± 0.4
Unspecified Leptospermum sp. Murraylands SA 1 0 ± 0
Northern Rivers NSW 6 17 ± 3.3
Stradbroke Island QLD 1 21.9 ± 1.2
Unknown 3 15.3 ± 13.5
aNSW: New South Wales, QLD: Queensland, SA: South Australia, TAS: Tasmania, VIC: Victoria
bNPA: non-peroxide activity.
doi:10.1371/journal.pone.0167780.t003
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Correlation between MGO and NPA in Australian Leptospermum honey
A strong positive linear correlation (r2 = 0.95, Pearson’s rho = 0.97, p<0.05) between MGO
concentration and the mean-squared NPA for the Australian Leptospermum species honeys
assessed in this study was observed, as shown in Fig 1. The mean-squared NPA was used to
investigate this relationship following studies on New Zealand manuka honey [23–25]. Based
on the New Zealand manuka relationship and data from the current study, an MGO concen-
tration of>260 mg/kg was identified as giving NPA levels of>10% and samples with>800
mg/kg MGO were identified as having high NPA of>20%.
The 12 honeys with the highest MGO concentration (>800 mg/kg, coloured green in Fig 1)
possessed the highest NPA ranging from 21.9–26.3% (Fig 1 and S2 Table). These samples were
sourced from NSW (Northern Rivers) or QLD (Stradbroke Island and Byfield) and were either
monofloral L. polygalifolium (n = 9) or other unknown Leptospermum sp. samples (n = 3).
Samples with MGO levels between 260–800 mg/kg (n = 40; coloured blue in Fig 1) had
NPA values of 13.1–22.1%. These samples were primarily sourced from Northern Rivers NSW
and most were monofloral L. polygalifolium honeys, although the highest MGO concentration
(704 mg/kg, NPA 22.1%) in this range was found in a monofloral L. liversidgei honey from the
same region.
Most samples that displayed detectable NPA (i.e. >9%) also possessed MGO above 260
mg/kg, with the exception of one L. continentale sample from Victoria, that had 262 mg/kg
MGO but no detectable NPA. Honeys with 207–260 mg/kg MGO (coloured red in Fig 1)
had NPA ranging from 0.0–12.1%. Three honey samples with MGO in this range did not
have any detectable NPA; of these two were monofloral L. continentale from Victoria, and
the other was a monofloral L. liversidgei honey from the Northern Rivers region of NSW.
All of the remaining honeys with MGO content in this lower range that had NPA were L.
polygalifolium samples (monofloral and multifloral) from the Northern Rivers region of
NSW.
Fig 1. Relationship between methylglyoxal and non-peroxide activity in Australian Leptospermum
honeys. Positive linear correlation between methylglyoxal (MGO) concentration and mean-squared non-
peroxide activity (NPA) in Australian Leptospermum honey samples (n = 80) represented by diamond
markers; green: MGO >800 mg/kg (NPA >20%), blue: MGO 260–800 mg/kg (NPA 10–20%), red: MGO <260
mg/kg (NPA <10%). Clover honey (purple triangle) served as a negative control with no detectable MGO or
NPA, and New Zealand manuka honey (yellow square) and MedihoneyTM (orange circle) both served as the
positive controls.
doi:10.1371/journal.pone.0167780.g001
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Change in non-peroxide antibacterial activity of Leptospermum honey
over time
Irish et al. tested the 80 Australian Leptospermum honey samples at the time of collection
(2006–2007) and found 61 had detectable NPA [12]. Repeat testing presented here found only
two samples had completely lost activity following seven year storage at 4˚C (Fig 2). These
samples were a monofloral L. liversidgei honey (initial activity: 12.7%) and a multifloral L. poli-
galifolium honey (initial activity: 9.8%). The remaining samples showed little to no loss of NPA
with<3% overall change in activity post storage for all but two samples. These two samples,
one monofloral L. polygalifolium honey and one unspecified Leptospermum sp. honey, had a
3.3% and 4.2% decrease in NPA, respectively. The mean NPA of the Leptospermum honeys
analysed by floral source was not significantly different to the initial NPA determined by Irish
et al. (Wilcoxon signed ranks tests, p = 0.669), indicating that the NPA is stable for at least
seven years under storage at 4˚C in the dark. The majority of the L. polygalifolium samples (18
out of 27 monofloral, five out of 11 multifloral samples) had increased NPA relative to the ini-
tial values determined seven years prior, and this may have been due to the conversion of
DHA to MGO in these samples over time.
Discussion
Alternatives for treating infections are urgently needed due to the major global health threat
posed by antibiotic resistance. The potent antibacterial activity of medical-grade manuka
honey, derived from the New Zealand variety of Leptospermum scoparium, is now well estab-
lished. The majority of its activity is attributed to its phytochemical constituents (in particular
MGO derived from its precursor DHA). The use of manuka honey for the management and
treatment of wounds could support current treatments and reduce the burden of antibiotic
resistance in the wound sector. However, New Zealand is unlikely to be able to support the
future growing demand for medical-grade honey.
Since the majority of the genus Leptospermum is endemic to and abundant in Australia, it is
likely that there is an untapped source of medical-grade honey in Australia. The antimicrobial
activity of Australian Leptospermum honey is assumed to be related to the same phytochemical
Fig 2. Non-peroxide activity (NPA) of Australian Leptospermum honey samples tested seven years
apart. Australian Leptospermum honey samples (n = 61) identified by Irish et al. (2011) as having NPA. Dark
grey boxes represent the NPA determined for the honeys at the time of collection (tested 2006–07). Light grey
triangles represent NPA tested seven years post-collection in 2014, following storage of the samples in the
dark at 4˚C.
doi:10.1371/journal.pone.0167780.g002
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components present in manuka honey, but this has never been tested. Therefore, the aim of
this study was to survey a range of Australian Leptospermum honeys for NPA and simulta-
neously quantify the major phytochemical constituents contributing to this activity. Since the
NPA of the collection of honeys used was previously determined [12], repeat testing also
allowed us to assess the changes in NPA after seven years.
We have now performed the most comprehensive chemical assay of Australian Leptosper-
mum honeys to date. Here we report a strong correlation (r2 = 0.95) between MGO content
and NPA in Australian Leptospermum honey. Honey samples with the highest MGO and NPA
also had the highest DHA concentrations, and these were mostly derived from either Leptos-
permum polygalifolium, L. liversidgei or mixed Leptospermum. We show increases in HMF lev-
els in the honey samples with age (consistent with previous reports [37]), and no correlation
between HMF and antibacterial activity (NPA), nor with the other phytochemicals (MGO,
DHA). Our data also demonstrate for the first time that the NPA is preserved for up to seven
years after original harvest when honeys are stored in the dark at 4˚C.
Methylglyoxal content correlates with non-peroxide antibacterial activity
in Australian Leptospermum honey
We demonstrate a positive linear relationship between MGO concentration and mean-squared
NPA in Australian Leptospermum honey. This is the first report of this type of relationship,
outside of New Zealand’s manuka honey [23, 38]. This indicates that like New Zealand man-
uka, the NPA of Australian Leptospermum honey is due primarily to MGO (derived from
DHA), and is a suitable alternative supply of medical-grade honey for use in wound care.
A minimum MGO concentration of approximately 200 mg/kg was seen in these Australian
Leptospermum honeys to produce a NPA of approximately 9% (Fig 1), which is the lowest
detectable NPA in this assay. This minimum detectable NPA concentration identified in this
survey is consistent with previous findings [23, 24, 38, 39]. Atrott and Henle [39] described a
strong correlation between MGO and NPA in New Zealand manuka honeys within a MGO
concentration of 200–800 mg/kg, which we also demonstrate. Although there are likely to be
other constituents of Leptospermum honeys that contribute to antibacterial activity [40, 41,
42], the tight correlation between MGO and NPA we have identified can be used by Australian
beekeepers to estimate the antibacterial, and subsequent commercial, value of their honey.
Some Australian Leptospermum honeys have exceptionally high MGO
and DHA concentrations
We show that 75 of the 80 Leptospermum honeys from the Irish et al. collection [12] possessed
both MGO and DHA (Table 1 and S1 Table). Honeys that possessed high MGO (>800 mg/kg)
were generally associated with high concentrations of DHA (>2000 mg/kg), as has been seen
in New Zealand manuka honey [25, 40]. The high levels of DHA and MGO in some of the
Australian Leptospermum honey samples in our study are comparable to or higher than those
observed in New Zealand manuka honey [23, 24, 39].
Many of these Australian honeys with very high levels of DHA and MGO honeys were clas-
sified as monofloral L. polygalifolium honeys or multifloral Leptospermum sp. from Northern
Rivers. MGO was also present in moderate concentrations (400–700 mg/kg) in monofloral
and multifloral samples of L. liversidgei and unspecified Leptospermum sp. honeys sourced
from the same region. This concurs with a recent study investigating the DHA content in Aus-
tralian Leptospermum nectar samples from Northern Rivers, which also showed high DHA in
the samples [26] and another study showing high DHA and MGO in Leptospermum honeys
from the same region [27].
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Most of the Leptospermum honeys from Irish et al. [12] study were from Northern Rivers,
however identifying new regions of Australia that may have a supply of high MGO and DHA
content honey (and therefore excellent antibacterial activity) would be of great value for apia-
rists seeking to capitalise on the production of medical-grade honeys and to wound care clini-
cians. Investigating further Australian Leptospermum honeys and nectars is warranted, in
particular taking in more geographical regions and Leptospermum species. We are currently
investigating these aspects of Australian honeys. Our results indicate that various Australian
Leptospermum honeys have similar important attributes to the well-characterised New Zealand
manuka honey, with significant promise in the wound care arena, particularly as an infection
control agent.
Storage of Leptospermum honey at low temperature preserves non-
peroxide activity (NPA)
Honey with potent NPA is highly sought after for the production of medical-grade honey
wound care products due to its potential clinical value in treating skin and wound infections.
We found that there was no significant change in the mean non-peroxide activity of the Leptos-
permum honeys (Fig 1) after seven years, establishing for the first time that this activity is
retained over a long period if stored away from light and at 4˚C. This suggests that the constit-
uents contributing to NPA are also stable under these storage conditions. The stability of NPA
over an extended period of time has positive implications. For example, storage of medicinal
honey products under these conditions can maintain the high levels of antibacterial activity
and also extend the shelf life of such products, thereby reducing waste and enabling greater
use.
Low temperature is also likely to have slowed or halted the conversion of DHA to MGO
[27, 40, 42, 43]. This could have other implications in the storage of medical-grade honeys. For
example, honeys fresh from the hive with a high DHA content should potentially be stored
under a particular set of conditions to maximise the conversion of DHA to MGO, and then
moved to storage at low temperatures (4˚C) to halt the conversion and maintain a high MGO
concentration. However, since the original analysis did not include chemical quantitation [12]
further investigation is needed.
Conclusions
The data reported here show that Australian Leptospermum honeys have potential for thera-
peutic use as antibacterial agents as they possess a stable, non-peroxide antibacterial activity
derived primarily from their phytochemical constituents. As is the case with New Zealand
manuka, NPA correlates strongly with the MGO concentration in the honey, and high levels
of DHA were also detected in many of the honey samples suggesting that there is an untapped
supply of antibacterial Leptospermum honey in Australia. As most of the Leptospermum genus
is endemic to Australia, it is likely that there are more valuable sources for medical-grade
honey, providing Australian apiarists the opportunity to benefit from the lucrative medicinal
honey market. An increased availability of medical-grade honey, together with scientific data
on how it acts to kill bacterial cells will encourage its use in mainstream medicine, helping to
reduce some of the burden of the antibiotic resistance crisis, particularly in wound care.
Supporting Information
S1 Fig. Regions of Australia where Leptospermumhoneys were sourced. Samples received
from Queensland (QLD) regions: Byfield (orange) and Stradbroke Island (green); New South
Wales (NSW) regions: Northern Rivers (blue) and Hunter (red); Victoria (VIC) region:
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Central (yellow) and South Australia (SA) region: Murraylands (purple).
(TIF)
S1 Table. Methylglyoxal, dihydroxyacetone and hydroxymethylfurfural levels in each
Australian Leptospermumhoney sample. a NSW: New South Wales, QLD: Queensland, SA:
South Australia, TAS: Tasmania, VIC: Victoria. Data represented as mean ± standard devia-
tion, range and % relative standard deviation (% RSD) calculated from two separate assays.
(PDF)
S2 Table. Non-peroxide activity and region of origin of each Australian Leptospermum
honey sample tested at the time of collection and seven years post-collection. a NSW: New
South Wales, QLD: Queensland, SA: South Australia, TAS: Tasmania, VIC: Victoria; b Non-
peroxide activity tested at the time of collection (2007 data) and seven years after collection
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